Silk Road Medical, Inc (SILK)
NASDAQ: SILK · IEX Real-Time Price · USD
27.07
+0.02 (0.07%)
At close: Jul 19, 2024, 4:30 PM
27.19
+0.12 (0.44%)
Pre-market: Jul 22, 2024, 7:00 AM EDT
Silk Road Medical Revenue
Silk Road Medical had revenue of $185.49M in the twelve months ending March 31, 2024, with 23.04% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $48.48M with 20.81% year-over-year growth. In the year 2023, Silk Road Medical had annual revenue of $177.13M with 27.77% growth.
Revenue (ttm)
$185.49M
Revenue Growth
+23.04%
P/S Ratio
5.80
Revenue / Employee
$391,323
Employees
474
Market Cap
1.08B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 177.13M | 38.50M | 27.77% |
Dec 31, 2022 | 138.64M | 37.16M | 36.62% |
Dec 31, 2021 | 101.48M | 26.25M | 34.89% |
Dec 31, 2020 | 75.23M | 11.87M | 18.74% |
Dec 31, 2019 | 63.35M | 28.80M | 83.33% |
Dec 31, 2018 | 34.56M | 20.30M | 142.37% |
Dec 31, 2017 | 14.26M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Owens & Minor | 10.42B |
Collegium Pharmaceutical | 566.92M |
Ironwood Pharmaceuticals | 413.55M |
Artivion | 368.21M |
MiMedx Group | 334.51M |
Innoviva | 311.59M |
Arcutis Biotherapeutics | 106.39M |
Relay Therapeutics | 35.33M |
SILK News
- 5 days ago - STOCKHOLDER INVESTIGATION: The M&A Class Action Firm Investigates Merger of Silk Road Medical, Inc. – SILK - GlobeNewsWire
- 6 days ago - STOCKHOLDER INVESTIGATION: The M&A Class Action Firm Investigates Merger of Silk Road Medical, Inc. - SILK - PRNewsWire
- 27 days ago - SILK Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Silk Road Medical to Boston Scientific - GlobeNewsWire
- 4 weeks ago - SILK ROAD MEDICAL INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Silk Road Medical, Inc. - SILK - Business Wire
- 4 weeks ago - ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Silk Road Medical, Inc. - PRNewsWire
- 4 weeks ago - Shareholder Alert: Ademi LLP investigates whether Silk Road Medical, Inc. has obtained a Fair Price for its Public Shareholders - PRNewsWire
- 4 weeks ago - Boston Scientific Adds Stroke Prevention To Vascular Portfolio Via Silk Road Medical's $1.3B Deal - Benzinga
- 4 weeks ago - Breaking News: Is Silk Road Medical's $27.50 Per Share Sale Price a Fair Deal? Johnson Fistel, LLP Investigates Deal Terms - GlobeNewsWire